QIAGEN erweitert sein QIAcuity-Portfolio für Genexpressionsanalysen und treibt so den Einsatz der digitalen PCR in Forschung und Biopharma weiter voran

Key Takeaway: QIAGEN is expanding its QIAcuity portfolio for gene expression analysis, enhancing the application of digital PCR in research and biopharma. This move indicates a strategic effort to advance technological capabilities in the field. The expansion aims to meet growing demands in gene expression studies.